AC
TEVA icon

Allstate Corporation’s Teva Pharmaceuticals TEVA Stock Holding History

Allstate Corporation’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-11,105
Closed -$101K – 519
2022
Q4 		$101K Buy
11,105
+891
+9% +$7.78K ﹤0.01% 577
2022
Q3 		$82K Buy
+10,214
New +$90.3K ﹤0.01% 576
2021
Q4 		– Sell
-32,801
Closed -$319K – 763
2021
Q3 		$319K Sell
32,801
-3,145
-9% -$29.4K 0.01% 613
2021
Q2 		$356K Sell
35,946
-2,794
-7% -$29.6K 0.01% 611
2021
Q1 		$447K Hold
38,740
– – 0.01% 573
2020
Q4 		$374K Sell
38,740
-4,569
-11% -$43.8K 0.01% 572
2020
Q3 		$390K Sell
43,309
-8,671
-17% -$91.7K 0.01% 498
2020
Q2 		$641K Sell
51,980
-16,457
-24% -$186K 0.02% 362
2020
Q1 		$615K Sell
68,437
-72,828
-52% -$746K 0.02% 310
2019
Q4 		$1.38M Buy
141,265
+87,198
+161% +$778K 0.03% 376
2019
Q3 		$372K Buy
54,067
+20,180
+60% +$155K 0.01% 450
2019
Q2 		$313K Sell
33,887
-27,832
-45% -$336K 0.01% 449
2019
Q1 		$968K Buy
61,719
+40,014
+184% +$706K 0.03% 300
2018
Q4 		$335K Buy
+21,705
New +$445K 0.01% 351

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Allstate Corporation's TEVA Position: Q1 2023 in Review

Allstate Corporation sold out of Teva Pharmaceuticals (TEVA) in Q1 2023, closing a stake of 11,105 shares — an estimated $101K sold.

Allstate Corporation first reported a position in TEVA in Q4 2018 and held it in 14 quarters. The position peaked at $1.38M in Q4 2019. 438 funds tracked by Wall St. Rank hold TEVA as of Q1 2023.

  • Allstate Corporation reported no remaining Teva Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Allstate Corporation sold 11,105 Teva Pharmaceuticals shares in Q1 2023, an estimated $101K.
  • Allstate Corporation first reported a position in Teva Pharmaceuticals in Q4 2018 and held it in 14 quarters.
  • Allstate Corporation's Teva Pharmaceuticals position peaked at $1.38M in Q4 2019.
  • 438 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2023.

Based on Allstate Corporation's 13F filing for Q1 2023, filed 10 May 2023.